tavanic 250 mg film-coated tablets
sanofi-aventis ireland limited t/a sanofi - levofloxacin - film-coated tablet - 250 milligram(s) - fluoroquinolones; levofloxacin
levofloxacin 5mg/ml solution for infusion (50ml vial)
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use
levofloxacin mylan solution for infusion 250mg/50ml
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use
levofloxacin mylan solution for infusion 500mg/100ml
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use
levofloxacin ibigen 5 mg/ml solution for infusion (50ml vial)
ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use
levoxa 250mg film-coated tablets
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - film-coated tablet - levofloxacin 250 mg - antibacterials for systemic use
levoxa 500mg film-coated tablets
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - levofloxacin - film-coated tablet - levofloxacin 500 mg - antibacterials for systemic use
tavanic 500mg film-coated tablet
sanofi malta limited - levofloxacin - film-coated tablet - levofloxacin 500 mg - antibacterials for systemic use
tavanic 5mg/ml solution for infusion
sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - levofloxacin - solution for infusion - levofloxacin 5 mg/ml - antibacterials for systemic use
levofloxacin krka 250 mg film-coated tablets
krka, d.d., novo mesto - levofloxacin hemihydrate - film-coated tablet - 250 milligram(s) - fluoroquinolones; levofloxacin - pharmacotherapeutic group: quinolone antibacterials, fluoroquinolones, - it is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): - acute bacterial sinusitis. - acute exacerbations of chronic bronchitis. - community-acquired pneumonia. - complicated skin and soft tissue infections